ATOM stock · RMD stock

ATOM vs RMD · rev $135.0K vs P/E 29, $37.68B cap

Atomera Inc (ATOM) versus ResMed Inc (RMD) — a side-by-side from cached financials, not a winner call.

Atomera Inc (ATOM) is a semiconductor equipment & materials company listed on US.

ResMed Inc (RMD) is a medical instruments & supplies company listed on US.

Latest reported ATOM revenue for 2024-12-31 was $135.0K. Net income was -$18.4M. Revenue was down 75.5% from 2023-12-31 to 2024-12-31. ATOM currently screens at market cap $341.1M.

RMD does not have a complete income-statement cache yet.

ATOM currently screens at market cap $341.1M. RMD currently screens at market cap $37.68B and trailing P/E 28.8.

Not investment advice. Open the ATOM and RMD stock pages for the full models.

Not investment advice.

Popular Stock Comparisons